Singapore’s Export Woes: Navigating Tariffs and Forecast Adjustments

Singapore's non-oil domestic exports fell by 4.6% in July 2025, with pharmaceuticals heavily impacting the decline. Analysts had predicted a 1.8% drop. Despite a free-trade agreement with the U.S., exports face a 10% tariff. Authorities caution that growth may slow as production adjustments to evade tariffs come to an end.


Devdiscourse News Desk | Singapore | Updated: 18-08-2025 06:00 IST | Created: 18-08-2025 06:00 IST
Singapore’s Export Woes: Navigating Tariffs and Forecast Adjustments
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.
  • Country:
  • Singapore

Data released on Monday shows Singapore's non-oil domestic exports fell by 4.6% in July, contrary to analysts' predictions of a 1.8% annual decline. Pharmaceuticals were a major factor in the decrease, raising concerns over Singapore's trade outlook as exports to key markets such as the U.S. and China declined.

This downturn in exports comes despite the Singaporean economy outperforming expectations in the first half of 2025, prompting the government to adjust its full-year growth forecast to 1.5% to 2.5%. However, concerns linger due to a 10% tariff imposed by the U.S., challenging Singapore's trade relations even under a free-trade agreement.

Prime Minister Lawrence Wong expressed his concerns during the national day rally, indicating uncertainty over potential future tariff hikes on specific sectors like pharmaceuticals and semiconductors. Authorities remain cautious, projecting export growth of 1% to 3% for the year while warning of possible vulnerability in the latter half of 2025.

(With inputs from agencies.)

Give Feedback